USX:RAPT - RAPT Therapeutics Inc RAPT Therapeutics Inc
Sector: Health Care, Industry: Biotechnology
Next Earnings: 9 May 2024
Add to Watchlist
   
Add Alert 


Yahoo Finance (Live Price)

USD 8.93    +0.53 (+6.31%)
Show Technical Chart | 1M    3M    6M    1Y    3Y    5Y         

27 Mar 2024


Loading...
Loading...
Loading...

General

CEO: Dr. Brian Russell Wong M.D., Ph.D.

IPO: 2019-10-31

Headquarters: US

Employees: 129

Homepage

Description

RAPT Therapeutics Inc is a clinical-stage immunology-based biopharmaceutical company. It is focused on discovering, developing, and commercializing oral small-molecule therapies for patients with some unmet needs in oncology and inflammatory diseases. The company pipeline products include FLX475, designed to selectively inhibit the migration of immunosuppressive regulatory T cells into tumors; and RPT193, designed to selectively inhibit the migration of type 2 T helper cells into inflamed tissues.

Your Holdings
Dashboard
Portfolio
Options

Tools
Screener
Watchlist
Alerts
Notes
Community
Forum
Blog
YouTube
Shared Portfolios
Shared Screeners

Collab with Brokerages
Moomoo x StocksCafe
Tiger x StocksCafe

Help
Quickstart Guides
StocksCafe Academy
StocksCafe Youtube Channel

About StocksCafe
Our Story
Send Feedback
Pricing
Market
Singapore
Hong Kong
Tokyo
Kuala Lumpur
United States
London
Shenzhen
Shanghai
Bombay
National (India)
Indexes
Singapore Savings Bonds
Singapore T-Bills
CoinGecko
Your Account
Settings
Subscriptions
Referrals
Messages
Profile
YouTube
Server T1

About · FAQs · StocksCafe © 2024 · Privacy · Terms